{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:31:02Z","timestamp":1787070662087,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The term \u201cMultiple Primary Malignant Neoplasms (MPMNs)\u201d refers to two or more unrelated primary malignant neoplasms that originate from single or different organs and occur in one patient. MPMNs have been divided into synchronous and metachronous based on time duration after first malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a hospital-based retrospective study conducted at a tertiary cancer institute in Northeast India. Clinicopathological factors of patients with multiple primary malignancies with at least one female genital tract malignancy attending the gynecological oncology outpatient department were observed. Those with ambiguous status of primary malignancy and incomplete treatment of first primary malignancy were excluded from the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 57 patients with MPMN, including one case of triple primary malignancy, were included in the study. 59.18% of cases had metachronous, and 40.81% had synchronous malignancies. The median time to the development of second primary malignancy was 60 months. Among the first diagnosed malignancies, cervix was the most common site (26.5%), followed by endometrium (20.4%) and ovary (14.28%), whereas ovarian malignancy was more commonly diagnosed second malignancy (38.77%), followed by endometrium (14.28%) and cervix (10.2%). In an analysis of synchronous malignancies, the most common genital tract involvement was seen with endometrium and ovary, with a predominance of low-grade endometrioid histology in 75% of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>As the cancer survivor population continues to increase in future, these patients must be comprehensively evaluated on follow-up, and a cognizance of prior treatment taken should be kept. In addition, it is vital that the clinicians keep a lookout for high-risk population in which genetic testing may be beneficial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmh.jmh_55_24","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T10:08:19Z","timestamp":1729159699000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological Characteristics of Multiple Primary Malignancies Involving Female Genital Tract at a Tertiary Cancer Institute of Northeast India"],"prefix":"10.4103","volume":"15","author":[{"given":"Eshwarya Jessy","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Command Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Barmon","sequence":"additional","affiliation":[{"name":"Department of Gynaecological Oncology, Dr. B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana","family":"Baruah","sequence":"additional","affiliation":[{"name":"Department of Gynaecological Oncology, Dr. B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimpy","family":"Begum","sequence":"additional","affiliation":[{"name":"Department of Gynaecological Oncology, Dr. B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"R1-20241019","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1186\/s12885-016-2876-y","article-title":"Temporal trends in the risk of developing multiple primary cancers:A systematic review","volume":"16","author":"Ye","year":"2016","journal-title":"BMC Cancer"},{"key":"R2-20241019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/CMAR.S57378","article-title":"Multiple neoplasms, single primaries, and patient survival","volume":"6","author":"Amer","year":"2014","journal-title":"Cancer Manag Res"},{"key":"R4-20241019","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2407-14-272","article-title":"Second primary cancer risk \u2013The impact of applying different definitions of multiple primaries:Results from a retrospective population-based cancer registry study","volume":"14","author":"Coyte","year":"2014","journal-title":"BMC Cancer"},{"key":"R6-20241019","doi-asserted-by":"crossref","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours:Challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"key":"R7-20241019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/ijmr.IJMR_347_20","article-title":"Cancer scenario in North-East India and need for an appropriate research agenda","volume":"154","author":"Shanker","year":"2021","journal-title":"Indian J Med Res"},{"key":"R8-20241019","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.7717\/peerj.13528","article-title":"Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in female patients with breast cancer or genitalia malignancies","volume":"10","author":"Xiao","year":"2022","journal-title":"PeerJ"},{"key":"R9-20241019","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3892\/mco.2022.2593","article-title":"Analysis and prediction of second primary malignancy in patients with breast cancer","volume":"17","author":"Long","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"R10-20241019","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.21037\/atm-21-1393","article-title":"Second primary malignancies associated with radiation therapy in cervical cancer patients diagnosed between 1975 and 2011:A population-based competing-risk study","volume":"9","author":"Wu","year":"2021","journal-title":"Ann Transl Med"},{"key":"R12-20241019","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000421-200008000-00011","article-title":"Multiple primary neoplasms at a single institution:Differences between synchronous and metachronous neoplasms","volume":"23","author":"Aydiner","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"R13-20241019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.1317","article-title":"Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996","volume":"93","author":"Dong","year":"2001","journal-title":"Int J Cancer"},{"key":"R14-20241019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinomas \u2013A prospective clinicopathologic study of 74 cases:A gynecologic oncology group study","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R15-20241019","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejogrb.2006.09.010","article-title":"Clinical analysis of synchronous primary neoplasms of the female reproductive tract","volume":"136","author":"Tong","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R16-20241019","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ijc.29462","article-title":"Risk of second primary malignancies in women with breast cancer:Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"137","author":"Ricceri","year":"2015","journal-title":"Int J Cancer"},{"key":"R19-20241019","doi-asserted-by":"crossref","first-page":"104350","DOI":"10.1016\/j.ejmg.2021.104350","article-title":"Extended ERN-GENTURIS Thematic Group 3. Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe","volume":"64","author":"Marmolejo","year":"2021","journal-title":"Eur J Med Genet"},{"key":"R20-20241019","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"R21-20241019","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4103\/IJPM.IJPM_1055_20","article-title":"Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies:A 5-year single institute experience with review of literature","volume":"64","author":"Vadgaonkar","year":"2021","journal-title":"Indian J Pathol Microbiol"}],"container-title":["Journal of Mid-life Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmh.jmh_55_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:34:25Z","timestamp":1787067265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmh.jmh_55_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jmh.jmh_55_24","relation":{},"ISSN":["0976-7800","0976-7819"],"issn-type":[{"value":"0976-7800","type":"print"},{"value":"0976-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-03-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}